The use of buprenorphine/naloxone to treat borderline personality disorder: a case report

BACKGROUND: Using traditional pharmacotherapy to treat Borderline Personality Disorder (BPD) such as mood stabilizers and second-generation antipsychotics has a lack of supporting evidence. Buprenorphine/Naloxone (BUP/N), a combination medication consisting of a partial opioid agonist, and a full op...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Brenna, Inch, Katelyn M., Kaschor, Brenna A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920565/
https://www.ncbi.nlm.nih.gov/pubmed/35287724
http://dx.doi.org/10.1186/s40479-022-00181-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920565/
https://www.ncbi.nlm.nih.gov/pubmed/35287724
http://dx.doi.org/10.1186/s40479-022-00181-1

Ejemplares similares